Arrive AI Inc.
For the period ended Sep 30, 2025. Filed Nov 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 14, 2025
ARAI$0.05-44.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Statements of Cash Flows
For the Nine Months Ended September 30, 2025 and 2024 (Unaudited)
| 2025 · 2024 | ||||
|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||
| Net loss | $(8,904,672) | $(3,199,606) | ||
| Adjustments to reconcile net loss to net cash used in operating activities | ||||
| Stock-based compensation | 3,134,655 | 880,120 | ||
| Depreciation and amortization | 31,048 | 21,792 | ||
| Amortization of discount on convertible debt | 357,333 | - | ||
| Amortization of issuance costs on convertible debt | 240,000 | - | ||
| Realized gain on investments | (46,491) | - | ||
| Unrealized depreciation on investments | 76,120 | - | ||
| Changes in operating assets and liabilities | ||||
| (Increase) decrease in | ||||
| Accounts receivable | (4,900) | - | ||
| Prepaid expenses | (108,910) | (63,407) | ||
| Other current assets | 3,458 | - | ||
| Increase (decrease) in | ||||
| Accounts payable | 43,148 | 408,485 | ||
| Accrued liabilities | 125,842 | 21,889 | ||
| Credit card payable | 4,938 | (28,720) | ||
| Net cash used in operating activities | (5,048,431) | (1,959,447) | ||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||
| Construction in progress | (87,850) | - | ||
| Proceeds from sales of investments | 3,018,635 | - | ||
| Purchase of investments | (4,967,259) | - | ||
| Net cash used in investing activities | (2,036,474) | - | ||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||
| Proceeds from sale of common stock, net | 448,056 | 2,031,682 | ||
| Purchase of treasury stock | (74,743) | - | ||
| Proceeds from the exercise of warrants, net | 573,896 | - | ||
| Repayments of note payables | (6,337) | (5,914) | ||
| Proceeds from issuance of convertible debt | 7,530,000 | - | ||
| Deferred offering costs | (698,570) | (100,000) | ||
| Net cash provided by financing activities | 7,772,302 | 1,925,768 | ||
| NET INCREASE (DECREASE) IN CASH | 687,397 | (33,679) | ||
| CASH, BEGINNING OF PERIOD | 129,318 | 325,472 | ||
| CASH, END OF PERIOD | $816,715 | $291,793 | ||
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION | ||||
| Cash paid for: | ||||
| Interest | $175,640 | $1,277 | ||
| Income taxes | $ | - | $ | - |
| SUPPLEMENTAL DISCLOSURE OF NONCASH INFORMATION | ||||
| Common stock issued as payment of offering costs | $6,927,869 | $ | - | |
| Common stock issued as settlement of legal expenses | $1,204,737 | $ | - | |
| Conversion of notes payable to common stock | $4,125,000 | $ | - | |
| Deferred offering costs recognized as additional paid-in capital | $1,741,750 | $ | - | |
| Cashless exercise of stock options | $9,269 | $ | - | |
- 6 -
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.